TherapeuticsMD, Inc.
TXMD
$0.9962
-$0.0138-1.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 667.00K | 547.00K | 234.00K | 313.00K | 502.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 667.00K | 547.00K | 234.00K | 313.00K | 502.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 667.00K | 547.00K | 234.00K | 313.00K | 502.00K |
| SG&A Expenses | 879.00K | 1.31M | 1.23M | 1.32M | 1.48M |
| Depreciation & Amortization | 100.00K | 96.00K | 180.00K | 133.00K | 637.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 979.00K | 1.41M | 1.41M | 1.46M | 2.11M |
| Operating Income | -312.00K | -859.00K | -1.18M | -1.14M | -1.61M |
| Income Before Tax | 83.00K | -567.00K | -1.05M | -809.00K | -1.58M |
| Income Tax Expenses | -31.00K | -- | -- | -- | -43.00K |
| Earnings from Continuing Operations | 114.00K | -567.00K | -1.05M | -809.00K | -1.54M |
| Earnings from Discontinued Operations | 138.00K | -42.00K | -40.00K | 75.00K | 658.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 252.00K | -609.00K | -1.09M | -734.00K | -883.00K |
| EBIT | -312.00K | -859.00K | -1.18M | -1.14M | -1.61M |
| EBITDA | -212.00K | -763.00K | -999.00K | -1.01M | -1.46M |
| EPS Basic | 0.02 | -0.05 | -0.09 | -0.06 | -0.08 |
| Normalized Basic EPS | -0.06 | -0.03 | -0.06 | -0.04 | -0.09 |
| EPS Diluted | 0.02 | -0.05 | -0.09 | -0.06 | -0.08 |
| Normalized Diluted EPS | -0.06 | -0.03 | -0.06 | -0.04 | -0.09 |
| Average Basic Shares Outstanding | 11.53M | 11.53M | 11.53M | 11.53M | 11.04M |
| Average Diluted Shares Outstanding | 11.53M | 11.53M | 11.53M | 11.53M | 11.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |